Skip to main content
NCBI home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;12(1):1–11. doi: 10.1111/j.1750-3639.2002.tb00417.x

Immunohistochemistry for the Prion Protein: Comparison of Different Monoclonal Antibodies in Human Prion Disease Subtypes

Gábor G Kovács 1,2,*, Mark W Head 3,*, Ivan Hegyi 4, Tristan J Bunn 3, Helga Flicker 1, Johannes A Hainfellner 1, Linda McCardle 3, Lajos László 5, Christa Jarius 1, James W Ironside 3, Herbert Budka 1,✉
PMCID: PMC8095765  PMID: 11770893

Abstract

Demonstration of the abnormal form of the prion protein (PrP) in the brain confirms the diagnosis of human prion disease (PrD). Using immunohistochemistry, we have compared ten monoclonal antibodies in PrD subtypes including sporadic and variant Creutzfeldt‐Jakob disease (CJD), fatal familial insomnia, Alzheimer's disease (AD), and control brains. CJD subgroups were determined using Western blot analysis for the protease‐resistant PrP type in combination with sequencing to determine the genotype at the methionine/valine polymorphism at codon 129 of the prion protein gene. None of the antibodies labeled given subgroups exclusively, but the intensity of immunoreactivity varied among morphologically distinct types of deposit. Fine granular or synaptic PrP deposits stained weakly or not at all with antibodies against the N‐terminus of PrP, and were visible in one case only with 12F10 and SAF54. Coarser and plaque type deposits were immunolabeled with all antibodies. The immunostaining patterns appear characteristic for the disease subgroups. Labeling of certain neurons in all cases irrespective of disease, and staining at the periphery and/or throughout the senile plaques of AD patients were also noted. Antibodies such as 6H4 and 12F10 failed to give this type of labeling and are therefore less likely to recognise non‐pathological PrP material in immunohistochemistry.

Full Text

The Full Text of this article is available as a PDF (741.1 KB).

†

Previous address

References

  • 1. Almer G, Hainfellner JA, Brucke T, Jellinger K, Kleinert R, Bayer G, Windl O, Kretzschmar HA, Hill A, Sidle K, Collinge J, Budka H (1999) Fatal familial insomnia: a new Austrian family. Brain 122:5–16. [DOI] [PubMed] [Google Scholar]
  • 2. Bell JE, Gentleman SM, Ironside JW, McCardle L, Lantos PL, Doey L, Lowe J, Fergusson J, Luthert P, McQuaid S, Allen IV (1997) Prion protein immunocytochemistry—UK five centre consensus report. Neuropathol Appl Neurobiol 23:26–35. [PubMed] [Google Scholar]
  • 3. Bodemer W (1999) The use of monoclonal antibodies in human prion disease. Naturwissenschaften 86:212–220. [DOI] [PubMed] [Google Scholar]
  • 4. Budka H, Aguzzi A, Brown P, Brucher JM, Bugiani O, Collinge J, Diringer H, Gullotta F, Haltia M, Hauw JJ, Iron‐side JW, Kretzschmar HA, Lantos PL, Masullo C, Schlote W, Tateishi J, Weller RO (1995) Neuropathological diagnostic criteria for Creutzfeldt‐Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 5:459–466. [DOI] [PubMed] [Google Scholar]
  • 5. Collinge J, Sidle KC, Meads J, Ironside J, Hill AF (1996) Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature 383:685–690. [DOI] [PubMed] [Google Scholar]
  • 6. Esiri MM, Carter J, Ironside JW (2000) Prion protein immunoreactivity in brain samples from an unselected autopsy population: findings in 200 consecutive cases. Neuropathol Appl Neurobiol 26:273–284. [DOI] [PubMed] [Google Scholar]
  • 7. Giaccone G, Canciani B, Puoti G, Rossi G, Goffredo D, Iussich S, Fociani P, Tagliavini F, Bugiani O. (2000) Creutzfeldt‐Jakob disease: Carnoy's fixative improves the immunohistochemistry of the proteinase K‐resistant prion protein. Brain Pathol 10:31–37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Hainfellner JA, Wanschitz J, Jellinger K, Liberski PP, Gullotta F, Budka H (1998) Coexistence of Alzheimer‐type neuropathology in Creutzfeldt‐Jakob disease. Acta Neuropathol 96:116–122. [DOI] [PubMed] [Google Scholar]
  • 9. Hegyi I, Hainfellner JA, Flicker H, Ironside JW, Hauw JJ, Tateishi J, Haltia M, Bugiani O, Aguzzi A, Budka H (1997) Prion protein immunocytochemistry: reliable staining protocol, immunomorphology, and diagnostic pitfalls. Clin Neuropathol 16:262–263. [Google Scholar]
  • 10. Ironside JW, Head MW, Bell JE, Will RG (2000) Laboratory diagnosis of variant Creutzfeldt‐Jakob disease. Histopathology 37:1–9. [DOI] [PubMed] [Google Scholar]
  • 11. Kitamoto T, Ogomori K, Tateishi J, Prusiner SB (1987) Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest 57:230–236. [PubMed] [Google Scholar]
  • 12. Korth C, Stierli B, Streit P, Moser M, Schaller O, Fischer R, Schulz‐Schaeffer W, Kretzschmar H, Raeber A, Braun U, Ehrensperger F, Hornemann S, Glockshuber R, Riek R, Billeter M, Wüthrich K, Oesch B (1997) Prion (PrPSc)‐specific epitope defined by a monoclonal antibody. Nature 390:74–77. [DOI] [PubMed] [Google Scholar]
  • 13. Kovács GG, Head MW, Bunn T, László L, Will RG, Iron‐side JW (2000) Clinicopathological phenotype of codon 129 valine homozygote sporadic Creutzfeldt‐Jakob disease. Neuropathol Appl Neurobiol 26:463–472. [DOI] [PubMed] [Google Scholar]
  • 14. Nakamura S, Ono F, Hamano M, Odagiri K, Kubo M, Komatsuzaki K, Terao K, Shinagawa M, Takahashi K, Yoshikawa Y (2000) Immunohistochemical detection of apolipoprotein E within prion‐associated lesions in squirrel monkey brains. Acta Neuropathol 100:365–370. [DOI] [PubMed] [Google Scholar]
  • 15. Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, Farlow M, Dickson DW, Sima AA, Trojanowski JQ, Petersen RB, Gambetti P (1996) Molecular basis of phenotypic variability in sporadic Creutzfeldt‐Jakob disease. Ann Neurol 39:767–778. [DOI] [PubMed] [Google Scholar]
  • 16. Parchi P, Giese A, Capellari S, Brown P, Schulz‐Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar H (1999) Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224–233. [PubMed] [Google Scholar]
  • 17. Parchi P, Zou W, Wang W, Brown P, Capellari S, Ghetti B, Kopp N, Schulz‐Schaeffer WJ, Kretzschmar HA, Head MW, Ironside JW, Gambetti P, Chen SG (2000) Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci USA 97:10168–10172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Piccardo P, Safar J, Ceroni M, Gajdusek DC, Gibbs CJ Jr (1990) Immunohistochemical localization of prion protein in spongiform encephalopathies and normal brain tissue. Neurology 40:518–522. [DOI] [PubMed] [Google Scholar]
  • 19. Privat N, Sazdovitch V, Seilhean D, LaPlanche JL, Hauw JJ (2000) PrP immunohistochemistry: different protocols, including a procedure for long formalin fixation, and a proposed schematic classification for deposits in sporadic Creutzfeldt‐Jakob disease. Microsc Res Tech 50:26–31. [DOI] [PubMed] [Google Scholar]
  • 20. Prusiner S (1997) Prion diseases and the BSE crisis. Science 278:245–251. [DOI] [PubMed] [Google Scholar]
  • 21. Puoti G, Giaccone G, Rossi G, Canciani B, Bugiani O, Tagliavini F (1999) Sporadic Creutzfeldt‐Jakob disease: co‐occurrence of different types of PrP(Sc) in the same brain. Neurology 53:2173–2176. [DOI] [PubMed] [Google Scholar]
  • 22. Schulz‐Schaeffer WJ, Giese A, Windl O, Kretzschmar HA (1996) Polymorphism at codon 129 of the prion protein gene determines cerebellar pathology in Creutzfeldt‐Jakob disease. Clin Neuropathol 15:353–357. [PubMed] [Google Scholar]
  • 23. Schulz‐Schaeffer WJ, Tschoke S, Kranefuss N, Drose W, Hause‐Reitner D, Giese A, Groschup MH, Kretzschmar HA (2000) The paraffin‐embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. Am J Pathol 156:51–56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Scott MR, Will R, Ironside J, Nguyen HO, Tremblay P, DeArmond SJ, Prusiner SB (1999) Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci USA 96:15137–15142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Van Everbroeck B, Pals P, Martin JJ, Cras P (1999) Antigen retrieval in prion protein immunohistochemistry. J Histochem Cytochem 47:1465–1470. [DOI] [PubMed] [Google Scholar]
  • 26. Vorberg I, Buschmann A, Harmeyer S, Saalmuller A, Pfaff E, Groschup MH (1999) A novel epitope for the specific detection of exogenous prion proteins in transgenic mice and transfected murine cell lines. Virology 255:26–31. [DOI] [PubMed] [Google Scholar]
  • 27. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG (1996) A new variant of Creutzfeldt‐Jakob disease in the UK. Lancet 347:921–925. [DOI] [PubMed] [Google Scholar]
  • 28. Windl O, Dempster M, Estibeiro JP, Lathe R, De Silva R, Esmonde T, Will R, Springbett A, Campbell TA, Sidle KC, Palmer MS, Collinge J (1996) Genetic basis of Creutzfeldt‐Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet 98:259–264. [DOI] [PubMed] [Google Scholar]
  • 29. Zahn R, Liu A, Luhrs T, Riek R, von Schroetter C, Lopez Garcia F, Billeter M, Calzolai L, Wider G, Wüthrich K (2000) NMR solution structure of the human prion protein. Proc Natl Acad Sci USA 97:145–150. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES